Back

Why carvedilol improve the long-term survival in heart failure patients? A difference in barorecepter-mediated blood pressure regulation between beta and beta/alpha blockers-

28 August 2016 (10:12 - 10:19)
Organised by:
Congress Presentation Part of: Drug treatment of hypertension Autonomic nervous system and humoral regulations ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Hiromi Yamamoto

Kinki University, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
Cardiovascular treatment among hypertensive patients in 12 African countries : EIGHT study
Doctor M. Antignac (Paris, FR)
Abstract Slides
Presentation thumbnail
Results of the ESCAPE trial: an italian, multi-centre, phase IV, randomized, controlled, open-label trial on the effects of canrenone in hypertensive patients
Professor G. Derosa (Pavia, IT)
Abstract
Presentation thumbnail
Rubus occidentalis extract significantly lowered systolic blood pressure in subjects with prehypertension: randomized, double-blinded, placebo controlled clinical trial
Associate Professor S. Hong (Seoul, KR)
Presentation thumbnail
Simplification of antihypertensive therapy in resistant arterial hypertension
Associate Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides
Presentation thumbnail
Improving blood pressure control beyond the guidelines
Assistant Professor A. Farcas (Cluj Napoca, RO)
Abstract Slides

Access the full session

Session thumbnail
Drug treatment of hypertension

The Event

Event poster

ESC Congress 2016

28 August 2016 10:12 CET
You may be interested in
thumbnail
Congress Presentation
Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.
27 August 2021
thumbnail
Congress Presentation
Autonomic dysfunction in HFrEF
21 May 2023
thumbnail
Congress Presentation
Intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs with systolic heart failure despite long-term therapy with beta-blockers
21 May 2022
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources